维普期刊资源整合服务平台（V6.5）

72篇 您的检索式：作者名="Byrski"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Founder mutations in the BRCA1 gene in polish families with breast ovarian cancer显示文摘	Gorski B Byrski T Huzarski T	2000	Am J Hum Genet2000，66，6：	1
2	Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients显示文摘	Gronwald J Byrski T Huzarski T	2009	J Clin Oncol272009，，：	1
3	Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy显示文摘	Byrski T Gronwald J Huzarski T	2010	J Clin Oncol2010，28，3：	1
4	Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients显示文摘	Byrski T Huzarski T Dent R	2009	Breast Cancer Res Treat2009，115，2：	1
5	Response toneoadjuvant therapy with cisplatin in BRCA1-positivebreast cancer patients 显示文摘	BYRSKI T HUZARSKI T DENT R	2009	Breast Cancer ResTreat2009，115，2：	1
6	Pathologic complete response rates in young women with BRCA1-positive breast cancers afterneoadjuvant chemotherapy显示文摘	Byrski T Gronwald J Huzarski T		0，，03：	1
7	Results of a phase II open-label, non-randomized trial of cisplatin chemo- therapy in patients with BRCA1-positive metastatic breast cancer显示文摘	Byrski T Dent R Blecharz P	2012	Breast Cancer Res2012，14，4：	1
8	Response to neo-adjuvant chemotherapy in women with BRCA1 -positive breast cancers显示文摘	Byrski T Gronwald J Huzarski T	2008	Breast Cancer Res Treat2008，108，：	1
9	Response to neoadjuvant therapy with cisplatin in BRCA1 -positive breast cancer patients显示文摘	Byrski T Huzarski T Dent R	2009	Breast Cancer Res Treat2009，115，：	1
10	Pathologic complete response rates in young women with BRCAl-positive breast cancers after neoadjuvant chemotherapy显示文摘	Byrski T Gronwald J Huzarski T	2010	J Clin Oneol2010，28，3：	1
11	Neoadjuvant therapy with cisplatin in BRCAl-positive breast cancer patients显示文摘	Gronwald J Byrski T Huzarski T	2009	J Clin Oncol2009，27，15：	1
12	Neoadjuvant therapy with cisplatin in BRCAI-positive breast cancer patients显示文摘	Gronwald J Byrski T Huzarski T	2009	J Clin Oncol2009，27，：	1
13	Pathologic complete re-sponse rates in young women with BRCA1-positive breast cancersafter neoadjuvant chemotherapy显示文摘	Byrski T Gronwald J Huzarski T	2010	J Clin Oncol2010，28，12：	1
14	Response to neoadjuvant therapy with cisplatin in BRCAl-positive breast cancer patients 显示文摘	Byrski T Huzarski T Dent R	2009	Breast Cancer Res Treat2009，115，2：	1
15	Pathologic complete re- sponse rales in young women with BRCAl-positive breast cancers after neoadjuvant chemotherapy 显示文摘	Byrski T Gronwatd J Huzarski T	2010	J Clin Oncol2010，28，3：	1
16	Pathologic complete response rates in young women with BRCA1- positive breast cancers after neoadjuvant chemotherapy 显示文摘	BYRSKI T GRONWALD J HUZARSKI T	2010	J Clin Oncol2010，28，3：	1
17	Response to neoadjuvant therapy with cisplatin in BRCAl-positive breast cancer patients显示文摘	Byrski T Huzarski T Dent R	2009	Breast Cancer Res Treat2009，115，2：	1
18	Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients显示文摘	Byrski T Huzarski T Gronwald J	2009	J Clin Oncol2009，115，2：	1
19	Founder mutations in the BRCA1 gene in polish families with breast-ovarian cancer显示文摘	GORSKI B BYRSKI T HUZARSKI T	2000	Am J Hum Genet2000，66，6：	1
20	Neoadjuvant therapy withcisplatin in BRCA1 - postive breast cancer patients 显示文摘	Gronwald J Byrski T Huzarski T	2009	J ClinOncol2009，，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示